Introduction Globally, an estimated 30% of new HIV infections occur among adolescents (15–
24 years), most of whom reside in sub-Saharan Africa. Moreover, HIV-related mortality …

Adolescents and youth living with HIV have poorer antiretroviral treatment (ART) adherence
and viral suppression outcomes than all other age groups. Effective interventions promoting …

Adolescents represent a growing proportion of people living with HIV worldwide and the
highest risk population group for treatment attrition and AIDS-related mortality. There is an …

Objectives Eighty-two percent of human immunodeficiency virus (HIV)–positive adolescents
live in Sub-Saharan Africa (SSA). Despite the availability of antiretroviral therapy (ART) …

Adolescents living in low-and middle-income countries (LMICs) are disproportionately
burdened by the global HIV/AIDS pandemic. Maintaining medication adherence is vital to …

Objective: Adolescent and young adult (AYA) populations (12–24 years) represent over 40%
of new HIV infections globally. Adolescence is sometimes characterized by high-risk sexual …

Background Achieving and maintaining high levels of medication adherence are required to
achieve the full benefits of antiretroviral therapy (ART), yet suboptimal adherence among …

Background Adolescents have gained increased attention because they are the only age
group where HIV related mortality is going up. We set out to describe the level and factors …

Background Adolescents living with HIV face substandard outcomes along the continuum of
care, including higher rates of poor adherence and virologic failure. Support groups have …

Objective: This systematic review aimed to identify antiretroviral therapy (ART) adherence
interventions specifically targeting adolescents and young adults (defined as ages 13–24) …